AAAAAA

   
Results: 1-10 |
Results: 10
LONG-TERM INTRAVENOUS PROSTAGLANDIN (EPOPROSTENOL OR ILOPROST) FOR TREATMENT OF SEVERE PULMONARY-HYPERTENSION
Authors: HIGENBOTTAM T BUTT AY MCMAHON A WESTERBECK R SHARPLES L
Citation: T. Higenbottam et al., LONG-TERM INTRAVENOUS PROSTAGLANDIN (EPOPROSTENOL OR ILOPROST) FOR TREATMENT OF SEVERE PULMONARY-HYPERTENSION, HEART, 80(2), 1998, pp. 151-155
ASSOCIATION BETWEEN BLOOD EOSINOPHIL COUNTS AND ACUTE CARDIAC AND PULMONARY ALLOGRAFT-REJECTION
Authors: TRULL A STEEL L CORNELISSEN J SMITH T SHARPLES L CARY N STEWART S LARGE S WALLWORK J
Citation: A. Trull et al., ASSOCIATION BETWEEN BLOOD EOSINOPHIL COUNTS AND ACUTE CARDIAC AND PULMONARY ALLOGRAFT-REJECTION, The Journal of heart and lung transplantation, 17(5), 1998, pp. 517-524
ALARMING ASTHMA PREVALENCE SECONDARY TO COCKROACH AND MITE ALLERGIES IN WEST-INDIAN ISLAND OF ROBINSON-CRUSOE-TRINIDAD
Authors: SHARPLES L NAYAK D KNAPP S
Citation: L. Sharples et al., ALARMING ASTHMA PREVALENCE SECONDARY TO COCKROACH AND MITE ALLERGIES IN WEST-INDIAN ISLAND OF ROBINSON-CRUSOE-TRINIDAD, Journal of allergy and clinical immunology, 101(1), 1998, pp. 11-11
EVALUATING THE DONOR POOL - IMPACT OF USING HEARTS FROM DONORS OVER THE AGE OF 49 YEARS
Authors: MERCER P SHARPLES L EDMUNDS J GITTINS R BAINES J WALLWORK J LARGE S PARAMESHWAR J
Citation: P. Mercer et al., EVALUATING THE DONOR POOL - IMPACT OF USING HEARTS FROM DONORS OVER THE AGE OF 49 YEARS, Transplantation proceedings, 29(8), 1997, pp. 3293-3296
LIPIDS, LIPOPROTEIN (A) AND CORONARY-ARTERY DISEASE IN PATIENTS FOLLOWING CARDIAC TRANSPLANTATION
Authors: PARAMESHWAR J FOOTE J SHARPLES L WALLWORK J LARGE S SCHOFIELD P
Citation: J. Parameshwar et al., LIPIDS, LIPOPROTEIN (A) AND CORONARY-ARTERY DISEASE IN PATIENTS FOLLOWING CARDIAC TRANSPLANTATION, Transplant international, 9(5), 1996, pp. 481-485
HEALTH TECHNOLOGY-ASSESSMENT - TMR TRIALS AND TRIBULATIONS
Authors: WALLWORK J SCHOFIELD P CAINE N SHARPLES L BUXTON M
Citation: J. Wallwork et al., HEALTH TECHNOLOGY-ASSESSMENT - TMR TRIALS AND TRIBULATIONS, Lancet, 348(9038), 1996, pp. 1386-1386
WHO WAITS LONGEST FOR HEART AND LUNG TRANSPLANTATION
Authors: SHARPLES L BELCHER C DENNIS C HIGENBOTTAM T WALLWORK J
Citation: L. Sharples et al., WHO WAITS LONGEST FOR HEART AND LUNG TRANSPLANTATION, The Journal of heart and lung transplantation, 13(2), 1994, pp. 289-291
HEART-LUNG TRANSPLANTATION FOR END-STAGE RESPIRATORY-DISEASE IN PATIENTS WITH CYSTIC-FIBROSIS AT PAPWORTH-HOSPITAL
Authors: DENNIS C CAINE N SHARPLES L SMYTH R HIGENBOTTAM T STEWART S WREGHITT T LARGE S WELLS FC WALLWORK J
Citation: C. Dennis et al., HEART-LUNG TRANSPLANTATION FOR END-STAGE RESPIRATORY-DISEASE IN PATIENTS WITH CYSTIC-FIBROSIS AT PAPWORTH-HOSPITAL, The Journal of heart and lung transplantation, 12(6), 1993, pp. 893-902
PROGNOSIS OF PATIENTS WITH CYSTIC-FIBROSIS AWAITING HEART AND LUNG TRANSPLANTATION
Authors: SHARPLES L HATHAWAY T DENNIS C CAINE N HIGENBOTTAM T WALLWORK J
Citation: L. Sharples et al., PROGNOSIS OF PATIENTS WITH CYSTIC-FIBROSIS AWAITING HEART AND LUNG TRANSPLANTATION, The Journal of heart and lung transplantation, 12(4), 1993, pp. 669-674
OBLITERATIVE BRONCHIOLITIS (OB) IN 120 CONSECUTIVE HEART-LUNG TRANSPLANTS (HLT)
Authors: TAMM M SHARPLES L DENNIS C WALLWORK J HIGENBOTTAM TW
Citation: M. Tamm et al., OBLITERATIVE BRONCHIOLITIS (OB) IN 120 CONSECUTIVE HEART-LUNG TRANSPLANTS (HLT), The American review of respiratory disease, 147(4), 1993, pp. 197-197
Risultati: 1-10 |